Marimed (MRMD) Net Margin (2011 - 2026)

Marimed (MRMD) has 16 years of Net Margin data on file, last reported at 9.54% in Q1 2026.

• Net Margin for Q1 2026 came in at 9.54%, up 491.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 7.81% (up 256.0% YoY), and the FY2025 annual result was 9.04%, down 116.0% from the prior year.
• Net Margin rose to 9.54% in Q1 2026 per MRMD's latest filing, from 11.14% in the prior quarter.
• Over five years, Net Margin peaked at 13.56% in Q1 2022 and troughed at 26.06% in Q4 2023.
• A 5-year average of 4.57% and a median of 3.41% in 2024 frame the typical range for Net Margin.
• The sharpest annual moves came in 2022 and 2023: Net Margin soared 3388 bps in 2022, then sank 3934 bps in 2023.
• A 5-year view of Net Margin shows it stood at 13.27% in 2022, then plunged by 296 bps to 26.06% in 2023, then advanced by 19 bps to 21.22% in 2024, then jumped by 47 bps to 11.14% in 2025, then rose by 14 bps to 9.54% in 2026.
• Business Quant data shows MRMD's Net Margin at 9.54% in Q1 2026, 11.14% in Q4 2025, and 7.21% in Q3 2025.